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INTRODUCTION
Stroke is a major cause of death worldwide accounting for nearly 10% of all deaths, with 85% of all stroke deaths occur in the developing world. [1] Stroke incidence and case-fatality vary widely from country to country, but recent research, based on best available evidence, has supported the view that both are closely linked to measures of a country's wealth, such as gross domestic product. [2] [3] Eastern Europe, north Asia, south Pacific and central Africa had the highest stroke mortality rates. There was a 3.5-fold increase in stroke mortality in low-income countries compared to middle-and high-income countries. Furthermore, stroke mortality has been shown to increase as economic conditions deteriorate; this increase is thought to be linked to increased case-fatality, rather than increased incidence. [4] [5] The World Health Organisation's MONICA study from the period 1980-1995 demonstrated mean 28-day case-fatality rates of 18% in Sweden, 19% in Denmark, 21% in Finland, 28% in Beijing, China, 33% in Italy, 40% in Russia and 45% in Poland. [5] A 2009 systematic review of 56 population-based stroke incidence studies from 1970-2008 revealed a mean decrease in 1-month case-fatality between 1980-89 and 2000-08 from 21.5% to 19 .8% in high income countries and from 35.2% to 26.6% in low to middle income countries. [3] This decrease has occurred against a background of demographic changes leading to an increasingly elderly population, and is almost certainly due to improved management of stroke survivors. [6, 7] Declines in 1-year case-fatality have also been reported recently. [8] In contrast, a long-term study in Oxfordshire, UK saw no significant change in incident stroke case-fatality from 1981 to 2004 (17.2% vs. 17.8%), despite a dramatic fall in overall incidence. [9] Results from long-term follow-up of stoke cases are more variable, in part due to varying exclusion and inclusion criteria. [10] [11] [12] [13] However, recent studies from the developed world suggest 3-and 5-year case-fatality rates of 43-54% and 53-60% respectively. [14] [15] [16] [17] [18] Reports of post-stroke deaths in sub-Sahara Africa (SSA) are, however, unreliable due to factors such as, the small number of deaths occurring in hospitals, limited death certification and lack of coverage of primary health care services. [19] [20] Previous studies looking at mortality amongst those admitted to hospital have demonstrated a one month case-fatality of between 27% and 46%. [21] [22] [23] We are not aware of any previous studies of case-fatality of incident stroke cases in SSA. [19] The aim of this study was to establish case-fatality over 3 years post-stroke within an incident population. Such data are needed to help inform clinicians, government agencies and other healthcare providers in SSA. [2] [3] 
PARTICIPANTS AND METHODS
Participants were part of a stroke incidence study, details of which have been described previously. [24] A favourable ethical opinion was obtained from the National Institute of Medical Research in Tanzania and from the Newcastle and Northumberland Joint Ethics Committee, UK.
Recruitment
During the incidence phase of our study we used two methods of case ascertainment. [24] The Tanzanian geographical divisions of the city of Dar-es-Salaam. The study described here is based on data from the Hai DSS. Due to poorer coverage of primary healthcare services in the Dar-esSalaam DSS we were unable to follow-up all these cases. The Hai DSS has been described previously as part of the Adult Morbidity and Mortality Project (AMMP). [25] From within a population of 159,814, a total of 453 strokes were recorded in Hai during this time period, 132 identified by TSIP and 346 by VA, with 25 cases identified by both systems. The ageadjusted incidence was 108.6 per 100,000 (95% CI 89.0 to 130.9).
Tanzanian Stroke Incidence Project
All 132 patients were followed-up prospectively after recruitment by a network of key 
Verbal autopsy
The system of VA used has been well described and validated previously. [25] [26] It is described briefly here. All deaths occurring in the study site were picked up as part of a long established system for VA and those identified as being due to stroke within the study period were included in the study. Deaths are coded independently by two coders and in case of disagreement a third coder's opinion is sought and the majority diagnosis recorded. To avoid double-counting we linked deaths within the study period occurring in patients identified by TSIP, with VA data using a variety of characteristics, including name and age, to determine the matches. All data were double entered into an EPI INFO data entry system. Fifteen percent of VAs from the study period had no cause of death ascribed, due to loss of forms.
For these we imputed a cause of death by randomly selecting (without replacement) from a pool of deaths from the same age, sex and area group as the missing deaths from one year before and one year after the year of the missing death. This process left the cause-specific mortality structure unchanged. Cause of death was assigned by applying the International Classification of Diseases 10 (ICD-10) to determine the underlying cause of death. [27] Stroke deaths in the VA system were defined as those where the probable cause of death was a cardiovascular disorder (cerebrovascular disease and hypertension) excluding unspecified cardiovascular disorders, congestive cardiac failure and ischaemic heart disease.
The date of the occurrence of the stroke was recorded as part of the VA, enabling fatality after 28 days and 3 years to be computed.
Statistics
Confidence intervals (CIs) for percentages are based on the normal approximation to the binomial distribution. A Kaplan-Meier survival curve is presented. All cases still alive at the end of the study period are censored. This means that data for the entire 6 years of the study can be considered, with data for those dying at greater than the minimum 3 years follow-up used.
RESULTS

Tanzanian Stroke Incidence project
Only one case of subarachnoid haemorrhage was identified by CT head scan. This patient, who died after 10 days, is excluded from further analysis because it was felt that the difference aetiology and prognosis of SAH would make this patient un-representative of the cohort as a whole. For one patient date of death was not known and this patient was excluded from further analysis. For those in whom date of death was known (n = 86), the median time to death was 101 days (range 0-1765). Case-fatality rates are presented in Table 1 and the mean ages of those dead and alive at 28 days and 3 years in Table 2 . A Kaplan-Meier survival curve is shown in Figure 1 .
Of those identified by TSIP, 63 cases had a CT scan carried out within 15 days of incident stroke. Eleven (175%) had evidence of a haemorrhagic stroke and 52 (825%) were normal or had evidence of cerebral infarct. Although there was a difference in case-fatality between stroke sub-types at 28 days, with 3 deaths after haemorrhagic stroke (27.3%) and 10 subsequent to cerebral infarct (19.2%) this did not reach statistical significance (95% CI for difference in percentage -20.3 to 36.5). Three-year case-fatalities were 4 (36.4%) for haemorrhage and 26 (50.0%) for infarct (95% CI for the difference -17.9 to 45.1).
Verbal Autopsy
Excluding cases also identified by TSIP (n = 25), 321 stroke cases were identified by VA during the study period. As previously reported, for some cases a cause of death had to be analysis. Furthermore, no reliable date of stroke could be established in 69 cases. In some cases identified by the VA system, the stroke occurred before the start of the study period, but these cases should be balanced by those who had a stroke within the study period, but who died after the end of the study, and were therefore not include in the final figures. For the remaining 223 cases for which a date of stroke was available (69.5% of all unique VA cases), the timing of death, worst case scenario (as by definition all these cases died eventually) 28-day and 3-year 'case-fatality rates', are presented in Table 1 and age-and sex-specific casefatality rates at 28 days and 3 years in Table 2 and Table 3 respectively.
Case-fatality rates for our cohort are compared to those from other studies in SSA (primarily based on hospital-ascertained cohorts) and Europe in Table 4 . 
DISCUSSION
This is the first study in SSA of post-stroke case-fatality in an incident stroke population.
Previous studies of stroke mortality in SSA have tended to be hospital-based and have reported higher death rates (see Table 4 ), although long-term follow-up is often hampered by the inability to trace patients. [28] It is notable that almost 60% of deaths within the TSIP identified cohort were at home, rather than in hospital. Our lower case-fatality may reflect the fact that many cases of stroke in SSA are not reported. This may be due to a number of reasons, both economic and cultural. [29] Some strokes resulting in death soon after onset may not be recorded as stroke whilst some strokes will occur without formal diagnosis, with those with the more severe symptoms more likely to be admitted to hospital. Moreover, many people may choose to visit traditional pharmacies and healers for advice rather than seeking help from more formal healthcare services. [29] However, within TSIP efforts were made to identify stroke cases within the community and the project paid for transport to hospital, admission and investigative tests.
Tanzania is one of the poorest countries in the world and there is limited access to rehabilitation services. [30] However, post-stroke mortality for the combined TSIP and VA data at one month post-stroke in the Hai DSS bear comparison with those from many studies from the developed world. [3, 5] However, mortality rates at 3-years post-stroke, with over three-quarters of all cases having died, are noticeably higher. [14] [15] This is also apparent when considering the case-fatality rates from the TSIP data only. Indeed, follow-up of incident stroke cases from 4 independent studies in the UK and Australia report lower 5-year case-fatality rates than seen at 3 years post-stroke in our study. [12, 16, 18, 31] This may suggest that case-fatality rates at one month post-stroke are governed to a large extent by the nature of the stroke itself. Although death rates at 3 years may be influenced, in part, by the life expectancy of the background population, they may also suggest that long-term mortality may be reduced by more effective post-stroke care.
At 28 days, of those recruited to TSIP who underwent CT head scan at less than 15 days poststroke, haemorrhagic stroke was associated with a greater case-fatality rate than cerebral infarct, although the numbers were small and the difference did not reach statistical significance. These findings support previous hospital-based studies in SSA. [32] They are also broadly similar to those reported by Feigin et al in a systematic review of populationbased incidence studies. [3] The data in Table 2 reveal no significant difference in ages between those who had died, and those who were still alive, at 28 days post-stroke. At 3 years post-stroke (Table 3) , those who were dead were older at the time of stroke than those still alive, though this is only significant in those identified by VA. Clearly for many of those dying some time after the incident stroke, the stroke itself is less likely to have been the direct cause of death than complications of the stroke or other co-morbidity. However, this study was designed to estimate post-stroke mortality, regardless of the primary cause of death. Without a suitable control population we are unable to comment on how many deaths may have been unrelated to the incident stroke.
It would be inappropriate to consider the VA data as representing a direct measure of casefatality rates; rather it is the distribution of the duration between stroke and death.
Nevertheless, it provides a 'worst case scenario' as these figures are based only on stroke deaths, and we have no way of knowing how many incident cases of stroke, which were not picked up by TSIP, survived, though this is likely to be very few. Inclusion of the VA data therefore provides a sensitivity analysis, giving extremes based on the experience within the community for the case-fatality rates.
We acknowledge that the VA system is not ideal for identifying time from stroke to death.
The system was designed to identify the cause of death by interview with close family members, friends or carers. Where stroke was thought to be the primary cause of death, questions were asked about the date of onset of symptoms, weakness and paralysis to try to identify the date of stroke. We recognise that this information, gathered retrospectively, relies heavily on the recall of those interviewed for the VA, and, therefore, may be inaccurate. Nevertheless, we feel that the inclusion of these data adds substantially to the external validity of our findings, and provides a valuable sensitivity analysis -providing an estimate of the worst case scenario for 28-day and 3-year case-fatality rates.
Given the lack of previous comparable data from SSA we are unable to comment on longterm trends in post-stroke mortality. Globally, case-fatality rates from stroke and cardiovascular disease appear to be linked to measures of prosperity, with recent research indicating an increase in rates in Eastern Europe in the last 20 years. [2] [3] [4] [5] 33] Our results reveal that one-month case-fatality rates for the Hai district of Tanzania are similar to those reported for many low and middle income countries. Further research is needed to establish whether this is representative of Tanzania, and SSA, as a whole. In those surviving beyond one month post-stroke, effective management may help to reduce long-term mortality, but it is not clear how this should best be provided in a resource poor environment.
For example, with the lack of sufficiently trained therapists, programmes which involve the training of relatives to provide therapy may be appropriate. In this area, where there is no access to institutional care, the relatives already provide the day-to-day 'nursing' care for even the most disabled stroke patients. Currently in SSA there is a focus of effort in combating communicable diseases, such as HIV/AIDS. However, as the epidemiological transition continues in such countries the burden of non-communicable diseases, such as stroke, is likely to greatly increase. [19] 
